28
Oct
2025
TDC Technology Dedicated to Care srl
Exhibitor at CPHI Frankfurt 2025 stand 4.1A30, Finished Dosage Formulations
About Us
Categories
-
IT
-
2018On CPHI since
Company types
Event information
CPHI Frankfurt 2025
-
28 Oct 2025 - 30 Oct 2025
-
Messe, Frankfurt
-
Visit us at stand 4.1A30, Finished Dosage Formulations
Products Featured at CPHI Frankfurt 2025
-
Product GYNO APOLACT Vaginal capsules
Vaginal capsules with liposomal apo-lactoferrin, EU medical device. -
Product KELAPHER Cream
First topical form of Lactoferrin cream in liposome technology, patented EU medical device. -
Product SOMILUX Eye drop
Innovative Eye-drops based on liposomal lactoferrin plus hyaluronic acid, patented medical device. -
Product APOLACT® Nasale TDC spray
APOLACT Nasale TDC spray is a medical device class I. It contains a mixture of apolactoferrin and lactoferrin in liposomes with sorbitol specially designed for hygiene, hydration and protection of the nasal cavity. Liposomes are lipid spheres that allow the protection and release of Apo-lactoferr... -
Product APOLACT® TDC
Apolact TDC is a dietary supplement based on Apolactoferrin in liposomes, useful in case of increased need and / or deficiency of lactoferrin. Lactoferrin is an iron chelating glycoprotein involved in numerous biological mechanisms, present in breast milk and in numerous organic secretions: saliva, tears, ... -
Product VASOPURE®
VASOPURE is a Liymphatic drainage cream with chelating and proteolytic action. Useful for the treatment of cellulite blemishes and edema. Vasopure cream prepares the skin for manual lymphatic drainage massage thanks to the chelating, soothing and antioxidant action of Apolactoferrin in liposomes and MS... -
Product GYNO-APOLACT®
"Apolact vaginal capsules" is a medical device, class IIa, in vaginal capsules based on Apolactoferrin in liposomes to be used as an adjunct in the treatment and prevention of vaginal and cervico-vaginal infections such as bacterial, viral and fungal vaginitis (candidiasis) and in all cases of temporary al... -
Product SOMILUX
Patented eye-drops based on liposomal lactoferrin plus hyaluronic acid. Medical device class IIA. Available in single use or multidosage formulation.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance